Aroa Biosurgery (ASX:ARX) has just reported FY 2026 first half revenue of NZ$44.9 million, with a reported loss of NZ$1.3 million and basic EPS of NZ$0.0038 loss, while the trailing twelve months show...
网页链接Aroa Biosurgery (ASX:ARX) has just reported FY 2026 first half revenue of NZ$44.9 million, with a reported loss of NZ$1.3 million and basic EPS of NZ$0.0038 loss, while the trailing twelve months show...
网页链接免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。